QbD Group
    Upcoming Webinar

    Managing Lifecycle Complexity

    Controlling Compliance and Operational Pressure Across Regulatory and Pharmacovigilance

    As pharmaceutical organizations grow and evolve, Lifecycle Management becomes increasingly difficult to control. This webinar explores how complexity develops across Regulatory Affairs and Pharmacovigilance, and how to structure activities in a more scalable and cost-efficient way.

    Thursday, June 25, 2026
    3 PM CEST / 1 PM GMT
    Pharmacovigilance · Regulatory Affairs
    English

    In today's pharmaceutical environment, Lifecycle Management is no longer only a regulatory or pharmacovigilance challenge, it is an operational challenge.

    As organizations grow internationally, add products, integrate acquisitions, or expand into multiple markets, both Regulatory Affairs and Pharmacovigilance teams face increasing operational complexity. Activities become more interconnected, coordination becomes more difficult, and pressure grows to maintain compliance while controlling workload, timelines, and costs.

    This webinar explores how these challenges develop across three common operational scenarios:

    • Integration of new product types where internal expertise is limited
    • Growing portfolios with constrained internal resources
    • Expansion into new markets with limited local knowledge or operational capacity

    For each scenario, we will connect operational complexity with its impact on variations, submissions, safety reporting, compliance oversight, and cross-functional coordination.

    The session will also highlight:

    • Loss of control — Where lifecycle execution typically starts to lose control
    • Emerging risks — What risks emerge in terms of compliance, timelines, data consistency, and operational efficiency
    • Scalable structure — How organizations can structure Lifecycle Management activities in a more scalable and cost-efficient way

    We will conclude with case studies showing how an integrated Lifecycle Management approach helped stabilize operations, reduce complexity, and improve efficiency and cost control across Regulatory and Pharmacovigilance functions.

    What you'll learn

    • How operational complexity, workload, and compliance pressure develop across Regulatory Affairs and Pharmacovigilance activities
    • How common business scenarios impact variations, submissions, safety reporting, and cross-functional coordination
    • Where Lifecycle Management activities typically become inefficient or difficult to control
    • How to improve operational efficiency while maintaining compliance and managing resource constraints
    • How integrated Regulatory and PV approaches can support more scalable and cost-efficient operating models
    • Practical lessons from real-life cases where Lifecycle Management complexity was successfully managed

    Learn from the best

    Speakers

    Dr. Almudena del Castillo

    Dr. Almudena del Castillo

    Global Division Head of Drug Safety and Vigilance, QbD Group

    A Medical Doctor and Specialist in Family and Community Medicine, Almudena has built a career spanning pharmacovigilance, regulatory affairs, and drug safety across some of the industry's most prominent organisations, including Pfizer. Before joining QbD Group, she served as VP of Sales and Business Development at Pharmalex and PLG. She is currently Global Division Head of Drug Safety and Vigilance at QbD Group.

    Joanna Rapacz

    Joanna Rapacz

    RA & CMC Director and Qualified Person, QbD Group

    Joanna brings over 25 years of pharmaceutical industry experience to her role as RA & CMC Director and Qualified Person at QbD Group. Her expertise spans Regulatory Affairs, CMC strategy, GMP quality oversight, and compliance implementation, underpinned by a strong foundation in quality control and R&D. She supports pharmaceutical organisations across the full scope of development and international product authorisation.

    Starts in

    37Days
    21Hours
    50Min
    01Sec

    Register here

    Registration opens soon

    Join 200+ life sciences leaders

    Is this for you?

    Who should attend?

    This webinar is designed for leaders and professionals responsible for Regulatory Affairs and Pharmacovigilance operations in pharmaceutical organizations facing growing operational complexity.

    Heads and managers of Regulatory Affairs and Pharmacovigilance

    Professionals responsible for Lifecycle Management activities

    Teams managing variations, submissions, and safety reporting

    Organizations facing increasing operational complexity, workload, and compliance pressure

    Companies seeking more scalable and efficient Regulatory and PV operating models

    Keep watching

    More webinars

    Pharmacovigilance and Risk Management in Innovative Therapies On Demand Webinar

    Pharmacovigilance and Risk Management in Innovative Therapies

    PharmacovigilanceMay 15, 2025

    The webinar discusses the evolving pharmacovigilance and risk management environment of innovative therapies, emphasizing safety challenges in cell, CAR T, and RNA-based treatments, as well as gaps in regulation and surveillance strategies. Participants will gain insight into the origin and impact of safety concerns in these therapies, alongside ongoing developments in RNA-based treatments.

    Watch now

    We use cookies to enhance your experience

    We use essential cookies for site functionality and optional analytics cookies to improve our services. Read our Privacy Policy and Cookie Policy.